Summary of Purpose
Cerebral infarcts represent a major cause of morbidity/mortality in spite of therapeutics for a premature recanalisation (intravenous recombinant tissue plasminogen activator (rt-PA) and thrombectomy). Thrombolysis failure by the administration of rt-PA is frequent, in particular in proximal occlusion. Experimental studies suggest that neutrophils could play an important role in the thrombus development via the...Read More →
The following dates are available for this trial. Trial information last updated on 6 November 2017.
|1 Jul 2016||26 Oct 2016||1 Jul 2018||1 Nov 2018||1 Nov 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Bertrand LAPERGUE, MD
- Arturo Consoli, MD